- Home
- WKC vs IRON Comparison
WKC vs IRON Comparison
Compare WKC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKC
- IRON
- Stock Information
- Founded
- WKC 1984
- IRON 2017
- Country
- WKC United States
- IRON United States
- Employees
- WKC N/A
- IRON N/A
- Industry
- WKC Oil Refining/Marketing
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- WKC Energy
- IRON Health Care
- Exchange
- WKC Nasdaq
- IRON Nasdaq
- Market Cap
- WKC 1.6B
- IRON 1.4B
- IPO Year
- WKC N/A
- IRON N/A
- Fundamental
- Price
- WKC $27.79
- IRON $51.61
- Analyst Decision
- WKC Sell
- IRON Strong Buy
- Analyst Count
- WKC 4
- IRON 10
- Target Price
- WKC $29.00
- IRON $93.40
- AVG Volume (30 Days)
- WKC 622.2K
- IRON 381.1K
- Earning Date
- WKC 07-24-2025
- IRON 08-07-2025
- Dividend Yield
- WKC 2.88%
- IRON N/A
- EPS Growth
- WKC N/A
- IRON N/A
- EPS
- WKC 0.32
- IRON N/A
- Revenue
- WKC $40,669,100,000.00
- IRON N/A
- Revenue This Year
- WKC N/A
- IRON N/A
- Revenue Next Year
- WKC $3.88
- IRON N/A
- P/E Ratio
- WKC $85.64
- IRON N/A
- Revenue Growth
- WKC N/A
- IRON N/A
- 52 Week Low
- WKC $22.71
- IRON $30.82
- 52 Week High
- WKC $31.71
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- WKC 52.57
- IRON 56.99
- Support Level
- WKC $27.83
- IRON $48.87
- Resistance Level
- WKC $28.43
- IRON $54.13
- Average True Range (ATR)
- WKC 0.50
- IRON 2.31
- MACD
- WKC -0.07
- IRON 0.07
- Stochastic Oscillator
- WKC 46.50
- IRON 67.64
About WKC World Kinect Corporation
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.